• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-10

  The reference study systematically investigates sex differences in the development of angiotensin II-induced hypertension in conscious mice, revealing a pronounced hypertensive response in males compared to females. These findings highlight the protective role of female sex hormones and the complexity of baroreflex and sympathetic regulation, informing future experimental design in preclinical vascular research.

• ZK53: Reliable Human ClpP Activator for Mitochondrial Assays

  2026-06-10

  This article explores how ZK53 (SKU BA8004) addresses key experimental challenges in studies of mitochondrial dysfunction, cell viability, and cytotoxicity. By providing scenario-driven guidance, it demonstrates the compound’s reproducibility, selectivity, and translational relevance for biomedical researchers and lab technicians. ZK53’s validated performance and supplier reliability are highlighted for optimized research workflows.

• Hoechst 33258: Bis-Benzimide DNA Stain for Live Cell Analysi

  2026-06-09

  Hoechst 33258 is a cell-permeable bis-benzimide DNA stain offering robust, high-affinity labeling of AT-rich DNA in live and fixed cells. It supports fluorescence microscopy and flow cytometry with strong blue emission and stability under standard laboratory conditions. Its mechanism and limitations are clearly defined, enabling precise cell cycle and tumor microenvironment investigations.

• Phebestin: A Potent Aminopeptidase Inhibitor Against Malaria

  2026-06-09

  This study introduces phebestin, a bestatin-related aminopeptidase inhibitor, as a highly effective antiplasmodial agent with nanomolar activity against both chloroquine-sensitive and -resistant Plasmodium falciparum strains. The findings support aminopeptidase inhibition as a promising strategy to overcome malaria drug resistance and inform future therapeutic development.

• Reliable Protein Extraction with RIPA Lysis Buffer (Strong,

  2026-06-08

  This article addresses critical lab challenges in protein extraction and assay reproducibility, demonstrating how RIPA Lysis Buffer (Strong, without inhibitors) (SKU K1120) meets the needs of biomedical researchers. Scenario-driven Q&A blocks highlight evidence-based optimization, workflow compatibility, and product reliability, providing actionable insights for selecting and applying this robust buffer.

• LPS Maintains Hepatocyte Stemness via YAP1: Mechanisms and I

  2026-06-08

  Shao et al. reveal that high levels of portal vein lipopolysaccharide (LPS) sustain hepatocyte stemness through TLR4-mediated YAP1 activation. This study demonstrates how LPS can induce dedifferentiation of mature hepatocytes, highlighting a previously unappreciated regulatory axis with implications for liver regeneration research.

• Clozapine N-oxide (CNO): Chemogenetic Precision in GPCR and

  2026-06-07

  Explore how Clozapine N-oxide (CNO) advances neuroscience through selective chemogenetic modulation of GPCRs and interneuronal circuits. This in-depth analysis reveals unique insights into CNO’s mechanism, assay optimization, and its pivotal role in cutting-edge research.

• Tubastatin A: Precision HDAC6 Inhibition for Cardiac Cell De

  2026-06-06

  Explore how Tubastatin A, a selective HDAC6 inhibitor, advances understanding of pyroptosis and necroptosis in cardiac injury. This article offers deep mechanistic insights and practical protocol guidance for researchers in cardiovascular and translational biology.

• Filipin III: Benchmark Polyene Macrolide for Membrane Choles

  2026-06-05

  Filipin III, a polyene macrolide antibiotic, is a gold-standard reagent for cholesterol detection and visualization in biological membranes. Its high specificity for cholesterol microdomains enables precise experimental mapping, supporting research in membrane biology and immunometabolism. The compound’s mechanism, protocols, and common pitfalls are clarified herein for optimal laboratory use.

• SU5416 (Semaxanib): Advanced Strategies for Angiogenesis Inh

  2026-06-05

  SU5416 (Semaxanib) delivers precise VEGFR2 inhibition and immunomodulation, enabling researchers to dissect tumor angiogenesis and immune tolerance in preclinical models. This guide details experimental workflows, troubleshooting, and translational insights to maximize reproducibility and impact in cancer and vascular biology research.

• Bestatin (Ubenimex): Precision Tool for Aminopeptidase Resea

  2026-06-04

  Bestatin (Ubenimex) stands out as a highly selective inhibitor for dissecting aminopeptidase-driven pathways in cancer, plant biology, and multidrug resistance research. Its nanomolar potency, reproducibility, and unique mechanism make it an indispensable tool for advanced experimental workflows and troubleshooting.

• Firefly Luciferase mRNA (5-moUTP): Optimizing Bioluminescent

  2026-06-04

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) redefines the reliability and sensitivity of bioluminescent reporter assays by combining advanced 5-moUTP modification, Cap1 capping, and a stabilized poly(A) tail. This powerful reagent enables researchers to achieve robust mRNA delivery, enhanced translation, and low immunogenicity for gene expression analysis across in vitro and in vivo platforms.

• Structure-Based Discovery of SARS-CoV-2 NSP15 Inhibitors

  2026-06-03

  Vijayan and Gourinath utilized structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as potent natural product inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. Their work highlights NSP15 as a promising antiviral target and provides a foundation for further inhibitor validation in COVID-19 research.

• Selective Nanomolar IRAP Inhibitors via Bestatin Derivatives

  2026-06-03

  This study introduces a diastereo- and regio-selective synthesis of α-hydroxy-β-amino acid derivatives of Bestatin, yielding potent, nanomolar, and highly selective inhibitors of insulin-regulated aminopeptidase (IRAP). Structural and biochemical analyses elucidate new determinants of selectivity, providing valuable tools and insights for aminopeptidase-related disease research.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-06-02

  This study applies structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as high-affinity inhibitors of SARS-CoV-2 non-structural protein 15 (NSP15), a key RNA endoribonuclease implicated in viral immune evasion. The findings suggest that targeting NSP15 with these natural products could represent a promising avenue for novel COVID-19 therapeutics, pending further experimental validation.

15178 records 1/1012 page Next 12345 下5页 Last page